AbbVie Sued By Louisiana Pension Fund Over $54.5 Billion Shire Pharmaceuticals Deal

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

AbbVie Inc.’s $54.5 billion purchase of Shire Plc (SHP) to move its legal address abroad and lower its taxes could trigger significant capital-gains liability for shareholders, a Louisiana pension fund said.

The Shire acquisition is the largest of a recent wave of tax-inversion buyouts. AbbVie should be barred from holding a shareholder vote on the takeover until it addresses problems with the deal, including a coercive $545 million termination fee, the Plumbers & Steamfitters Local 60 Pension Plan said today in a Delaware Chancery Court suit.

Help employers find you! Check out all the jobs and post your resume.

Back to news